APPLICATION
ANDA203176
TYPE
ANDA
ORIGINAL APPROVAL
2012-05-22
LATEST ACTION
2015-01-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
NEVIRAPINEDiscontinued
NEVIRAPINE 200MG · TABLET · ORAL
Approval history
2015-01-20Labeling · Supplement 3 · standardAP
2013-07-23Labeling · Supplement 2 · standardAP
2013-05-30Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.